Navigation

TA143 Ankylosing spondylitis - adalimumab, etanercept and infliximab: guidance

The published full guidance on ankylosing spondylitis - adalimumab, etanercept and infliximab.

It presents the recommendations in a format suited to implementation by health professionals and NHS bodies.

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.